FiercePharma Reports on Top 20 Drugs based on U.S. Sales

FiercePharma publishes the top 20 drugs based on U.S. sales. Once again, AbbVie’s Humira is far ahead of the pack. This list supports the fact that the USA is approaching a $500 billion dollar drug market.  With intensive waves of new gene therapy and cell therapy, not to mention specialized oncology and rare disease treatments, the age of the blockbuster may be transitioning to the “Precision Era” and those that win will win big.  It may not be as forgiving for the losers.

